Jinan Zhuocheng Bio-Tech Co., Ltd.

Recently, our organization reviewed three veterinary drug management notifications issued by Thailand and Vietnam. The key contents and our comments are summarized below for the attention of relevant enterprises.

Thailand Notification SPS-THA-812: Revision of the List of Prohibited Veterinary Drugs and Maximum Residue Limits in Animal Food

Under the revised requirements, Melengestrol Acetate (MGA) and Trenbolone Acetate are permitted for use as implants in beef cattle, in line with the Codex Alimentarius Commission (CAC) requirements. In China, however, these substances are completely prohibited for use in food-producing animals. Relevant importers are advised to closely monitor the differences between Thai and Chinese regulatory requirements.

Olaquindox is subject to a zero-detection requirement in Thailand. Relevant exporters are advised to pay close attention to this requirement and ensure that products meet the applicable residue-control standards.

Thailand also adopts a differentiated regulatory approach for aquatic animals. For fish, veterinary drugs such as Florfenicol, Sarafloxacin, and Danofloxacin may be used under the applicable requirements. For shrimp, crab, and other crustaceans, only Oxytetracycline is permitted, while other antibacterial drugs are prohibited from being detected. Relevant aquatic-product enterprises should closely monitor these requirements, particularly with regard to residue control and product compliance.

Vietnam Notifications SPS-VNM-185 and SPS-VNM-189: Updates to the Classification and Quality Management Requirements for Veterinary Drugs, Veterinary Vaccines, and Aquatic Feed

Vietnam Notification SPS-VNM-185 mainly revises the control list for medium- and high-risk agricultural, forestry, and aquatic products. Combined with Notification SPS-VNM-189 concerning the draft veterinary drug management regulations, the two notifications provide a more comprehensive framework covering the full lifecycle of veterinary drug management.

The draft regulations cover a wide range of areas, including veterinary drug marketing authorization, import and export management, enhanced supervision of anesthetic veterinary drugs, electronic labeling, prescription management, advertising regulations, and the list of prohibited veterinary drugs.

Relevant veterinary pharmaceutical, aquatic-product, and international trade enterprises are advised to closely monitor the implementation of these regulatory requirements and assess their potential impact on product registration, export compliance, labeling, advertising, and residue control.